The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 37,831,794 | 2,376,369 | SH | SOLE | 2,376,369 | 0 | 0 | |||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 1,119,168 | 160,800 | SH | SOLE | 160,800 | 0 | 0 | |||
ALIGN TECHNOLOGY INC | COM | 016255101 | 15,734,195 | 74,605 | SH | SOLE | 74,605 | 0 | 0 | |||
ALIMERA SCIENCES INC | COM | 016259202 | 544,490 | 200,919 | SH | SOLE | 200,919 | 0 | 0 | |||
ALKERMES PLC | COM | G01767105 | 15,766,842 | 603,400 | SH | SOLE | 603,400 | 0 | 0 | |||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 128,128,346 | 10,493,722 | SH | SOLE | 10,493,722 | 0 | 0 | |||
ANAPTYSBIO INC | COM | 032724106 | 13,357,434 | 431,024 | SH | SOLE | 431,024 | 0 | 0 | |||
BIOGEN INC | COM | 09062X103 | 105,252,307 | 380,082 | SH | SOLE | 380,082 | 0 | 0 | |||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 195,162,580 | 1,885,811 | SH | SOLE | 1,885,811 | 0 | 0 | |||
CYTOKINETICS INC | COM | 23282W605 | 5,118,873 | 111,717 | SH | SOLE | 111,717 | 0 | 0 | |||
EHEALTH INC | COM | 28238P109 | 12,024,878 | 2,484,479 | SH | SOLE | 2,484,479 | 0 | 0 | |||
GOSSAMER BIO INC | COM | 38341P102 | 81,918 | 37,750 | SH | SOLE | 37,750 | 0 | 0 | |||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 2,298,138 | 666,127 | SH | SOLE | 666,127 | 0 | 0 | |||
INSMED INC | COM | 457669307 | 117,308,394 | 5,871,291 | SH | SOLE | 5,871,291 | 0 | 0 | |||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 19,229,298 | 5,655,676 | SH | SOLE | 5,655,676 | 0 | 0 | |||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 4,619,648 | 656,200 | SH | SOLE | 656,200 | 0 | 0 | |||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,261,650 | 64,700 | SH | SOLE | 64,700 | 0 | 0 | |||
PEAK BIO INC | COM | 70470P108 | 2,021,792 | 497,528 | SH | SOLE | 497,528 | 0 | 0 | |||
PROTHENA CORP PLC | COM | G72800108 | 99,929,264 | 1,658,577 | SH | SOLE | 1,658,577 | 0 | 0 | |||
PROVENTION BIO INC | COM | 74374N102 | 4,130,756 | 390,800 | SH | SOLE | 390,800 | 0 | 0 | |||
REVANCE THERAPEUTICS INC | COM | 761330109 | 97,535,422 | 5,283,609 | SH | SOLE | 5,283,609 | 0 | 0 | |||
SAGE THERAPEUTICS INC | COM | 78667J108 | 32,667,558 | 856,517 | SH | SOLE | 856,517 | 0 | 0 | |||
STAAR SURGICAL CO | COM | 852312305 | 60,193,338 | 1,240,077 | SH | SOLE | 1,240,077 | 0 | 0 | |||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 15,590,670 | 612,600 | SH | SOLE | 612,600 | 0 | 0 | |||
TACTILE SYSTEMS TECHNOLOGY I | COM | 87357P100 | 311,108 | 27,100 | SH | SOLE | 27,100 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 3,492,431 | 166,069 | SH | SOLE | 166,069 | 0 | 0 | |||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 173,921,379 | 625,414 | SH | SOLE | 625,414 | 0 | 0 | |||
UROGEN PHARMA LTD | COM | M96088105 | 217,315 | 24,500 | SH | SOLE | 24,500 | 0 | 0 | |||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 8,037,416 | 1,087,607 | SH | SOLE | 1,087,607 | 0 | 0 |